Skip to main content
Adverse Event (AE) Monitoring is the RoseRx Platform’s built-in pharmacovigilance feature. When enabled, the system uses AI to automatically detect potential adverse drug reactions mentioned in conversations, alert your team, and provide an appropriate response to the user.
Access Adverse Event Monitoring by selecting an agent from the Agents list and clicking the Adverse Events tab.

How it works

When a user describes a symptom, side effect, or negative experience related to a medicine or treatment, the AE monitoring system:

Detect

The AI analyzes each message in real time, looking for language that indicates a potential adverse event — such as descriptions of symptoms, side effects, or negative reactions.

Alert

When a potential adverse event is detected, the system immediately sends notifications to your configured pharmacovigilance contacts via email.

Respond

The agent displays your configured AE response template to the user, providing appropriate guidance and contact information.
Example scenario: A patient mentions “I’ve been experiencing a rash on my arms since I started taking the medication last week.” The system detects this as a potential adverse event, notifies your pharmacovigilance team, and shows the patient your configured response message with reporting contact details.

Enabling monitoring

To activate AE monitoring for your agent:
  1. Navigate to the Adverse Events tab
  2. Toggle the Enable Adverse Event Monitoring switch to on
Once enabled, the remaining configuration options become available.
AE monitoring only applies to conversations that occur after it is enabled. It does not retroactively scan previous conversations.

Detection sensitivity

The detection sensitivity slider controls how aggressively the system identifies potential adverse events. Choose the level that best balances thoroughness with practical workload for your pharmacovigilance team.
Start with Medium sensitivity and adjust based on your team’s experience. Higher sensitivity catches more genuine events but also increases the number of alerts your team needs to review.

Detection policies

Two policy settings control when a mention becomes an adverse event signal:

Detection Policy

Educational Inquiry Policy

Controls how the system treats educational or hypothetical side-effect questions (e.g. “What are the common side effects of this medication?”):

Keyword lists

Tune detection with three keyword lists specific to your product and therapy area: You can also define side-effect severity rules — mapping specific symptoms (and their aliases) to a severity level — so detected events arrive pre-classified for your team.
Include both clinical terms and everyday language in Reportable Reactions. Patients rarely use formal medical terminology.

Testing your configuration

The Adverse Events tab includes a built-in preview tool: paste a sample patient message (and optionally prior conversation turns) to see exactly how the detector scores it, which triggers fired, and whether an AE signal would be created. Use it to validate your keyword lists and policies before publishing.

Advanced detection tuning

For teams that need finer control, the Advanced section exposes:
  • Detection thresholds — Adjust the score at which the evaluator is triggered and the score at which an AE signal fires.
  • Context weights — Tune how much product mentions, prior product links, and report language contribute to the detection score.
  • Gated evaluator — An optional, bounded AI second-pass that reviews borderline cases, with a configurable model tier and maximum score adjustment.
Most teams won’t need to change these — the sensitivity levels above adjust them automatically.

AE response template

Configure the message your agent displays when a potential adverse event is detected. This message replaces the agent’s normal response and provides the user with clear guidance on what to do next.
  • Maximum length: 2,000 characters
A good AE response template should:
  • Acknowledge the user’s concern
  • Explain that the information has been noted for review
  • Provide clear instructions for reporting the event
  • Include relevant contact information
  • Advise the user to seek medical attention if needed
Example template:
Thank you for sharing this information. Your safety is our priority. We have noted your experience and our pharmacovigilance team has been notified. If you are experiencing a medical emergency, please contact your doctor or call emergency services immediately. You can also report this experience directly by contacting us at the details below.

Reporting contact information

Provide the contact details that appear in AE notifications and may be referenced in the response template.

Notification recipients

Add the email addresses of team members who should receive alerts when a potential adverse event is detected.
  • Maximum recipients: 20
All listed recipients receive an email notification for every detected adverse event. Include your pharmacovigilance team, medical affairs contacts, and any other stakeholders required by your organization’s pharmacovigilance procedures.
Adverse event monitoring is an assistive tool — it does not replace your organization’s formal pharmacovigilance processes. Always ensure detected events are reviewed and reported through your established regulatory reporting pathways.

Best practices

  • Enable monitoring before publishing — Ensure AE monitoring is configured and active before your agent goes live
  • Craft a thorough response template — The AE response is often the first thing a concerned user sees. Make it reassuring, clear, and actionable
  • Include multiple contact methods — Provide email, phone, and website options so users can report through their preferred channel
  • Review alerts promptly — Establish an internal process for triaging and responding to AE notifications within your required timeframes
  • Refine sensitivity over time — Monitor the volume and quality of alerts and adjust the sensitivity level as you gather real-world data